For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...

A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

TOLEDO - NAMSA, a medical device testing and regulatory consulting firm, has acquired Labcorp’s (NYSE:LH) Early Development medical device testing business, according to a press release issued ...

There’s been a lot of talk lately about a potential merger between Quest Diagnostics and Labcorp. These two companies are huge players in the medical testing world, and if they join forces, it could ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

LabCorp recently announced the clinical availability of Labcorp Plasma Complete, a liquid biopsy test designed to aid oncologists in tailoring personalized treatment plans for patients with advanced ...

Labcorp will host a fireside chat at the J.P. Morgan Healthcare Conference. Get details on the Labcorp investor conference, ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced new capabilities ...

LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...